The Panomles Approach in Neurodegenerative Disorders

被引:3
|
作者
Szatmari, Balazs [1 ]
Balicza, Peter [2 ]
Nemeth, Gyorgy [1 ]
Molnar, Maria Judit [2 ]
机构
[1] Gedeon Richter Plc, Med Div, Budapest, Hungary
[2] Semmelweis Univ, Inst Genom Med & Rare Dis Orders, Budapest, Hungary
关键词
Omics; classification; neurodegenerative disorders; multidisciplinary approach; genetics; imaging; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TREM2; VARIANTS; PET; PATHOLOGY; NEUROINFLAMMATION; SAFETY;
D O I
10.2174/0929867324666170705120038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The molecular genetic technologies revolutionized the diagnostics of many disorders. Thanks to the new molecular techniques and the rapid improvement of the information technologies the number of mendelien inherited disorders has increased rapidly in the last five years. The omics era brought radical changes in the understanding of complex disorders and the underlying pathomechanisms. However, in most complex disorders the genome wide association studies could not clarify the genetic background even for disorders where a very strong heritability had been observed. Objective: In this paper the changing concept of the neurodegenerative disorders is discussed. The traditional classification of these disorders was purely based on clinical symptoms and morphological signs in the last century. Identifying the signature lesions of various neurodegenerative disorders may reveal a common pathological pathway in these disorders, New neuroimaging methods provided additional tools to assess pathological pathways in vivo already in the early stages of the diseases, Visualizing in vivo amyloid deposits and neuroinflammation improved our understanding of their role in various neurodegenerative disorders. Genetics may be the most precise way to identify the background of these disorders, However, there is only limited number of cases where true association can he proved between the disorder and the genetic mutations. Most of the neurodegenerative disorders seem to be multifactorial and cannot be traced back to one single cause. Conclusion: In conclusion, shifting from a classification based on symptomatology only to a modern multidisciplinary approach, based on the constantly evolving panomics findings, would improve our understanding of neurodegenerative diseases and could be the basis of novel therapeutic research.
引用
收藏
页码:1712 / 1720
页数:9
相关论文
共 50 条
  • [31] Neurodegenerative disorders -: Not guilty
    López, JC
    NATURE REVIEWS NEUROSCIENCE, 2002, 3 (04): : 258 - 259
  • [32] Identification of common therapeutic targets for selected neurodegenerative disorders: An in silico approach
    Ahmad, K.
    Baig, M. H.
    Gupta, Girish Kumar
    Kamal, M. A.
    Pathak, Neelam
    Choi, I.
    JOURNAL OF COMPUTATIONAL SCIENCE, 2016, 17 : 292 - 306
  • [33] Apoptosis in neurodegenerative disorders
    Mochizuki, H
    Mori, H
    Mizuno, Y
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1997, (50): : 125 - 140
  • [34] Neurodegenerative Disorders and Sleep
    Malhotra, Raman K.
    SLEEP MEDICINE CLINICS, 2022, 17 (02) : 307 - 314
  • [35] Nanotechnology for neurodegenerative disorders
    Re, Francesca
    Gregori, Maria
    Masserini, Massimo
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 : S51 - S58
  • [36] A new insight into thymosin β4, a promising therapeutic approach for neurodegenerative disorders
    Shomali, Navid
    Baradaran, Behzad
    Ghodrati, Mina Deljavan
    Akbari, Morteza
    Hemmatzadeh, Maryam
    Mohammadi, Hamed
    Jang, Yue
    Xu, Huaxi
    Shotorbani, Siamak Sandoghchian
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3270 - 3279
  • [37] Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
    Advani, Dia
    Gupta, Rohan
    Tripathi, Rahul
    Sharma, Sudhanshu
    Ambasta, Rashmi K.
    Kumar, Pravir
    NEUROCHEMISTRY INTERNATIONAL, 2020, 140 : 104841
  • [38] Iron and neurodegenerative disorders
    Thompson, KJ
    Shoham, S
    Connor, JR
    BRAIN RESEARCH BULLETIN, 2001, 55 (02) : 155 - 164
  • [39] Neuroregeneration in neurodegenerative disorders
    Enciu, Ana M.
    Nicolescu, Mihnea I.
    Manole, Catalin G.
    Muresanu, Dafin F.
    Popescu, Laurentiu M.
    Popescu, Bogdan O.
    BMC NEUROLOGY, 2011, 11
  • [40] MicroRNAs in Neurodegenerative Disorders
    Shunliang Xu
    CURRENT GERIATRICS REPORTS, 2012, 1 (04): : 214 - 218